Magnetic Cell Separation Using CD52 Markers

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for separating cells of interest from mixed biological samples, particularly in dry state on inert substrates, face challenges in efficiently isolating spermatozoa from epithelial cells without DNA alteration and require expensive technologies or skilled operators.

Innovation Solution

A method involving a serum-free buffer with Phosphate buffered saline and EDTA, combined with magnetic particles that specifically bind to the CD52 marker on spermatozoa, allows for direct or indirect coupling and subsequent magnetic separation, avoiding DNA lysis and enabling efficient enrichment of spermatozoa without expensive equipment or skilled operators.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional cell separation methods are used on dry state samples, then cell separation can be achieved, but DNA integrity is altered and contamination occurs

Engineering Contradiction:
ImproveDNA integrityVSAvoidcontamination
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies preliminary action by performing cell recovery and magnetic particle coupling before DNA extraction. Cells are recovered from the inert substrate, coupled to magnetic particles, and separated while still intact. This preliminary separation prevents DNA degradation and contamination that would occur if DNA extraction were performed on mixed samples first. The critical step of separating spermatozoa from epithelial cells happens before any DNA processing, thereby preserving DNA integrity and reducing contamination risks.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent extracts the disturbing part (epithelial cells) from the system before DNA analysis. By using magnetic particles that specifically bind to CD52 markers on spermatozoa, the method extracts and removes epithelial cells from the sample through magnetic separation. This extraction of unwanted cells before DNA extraction prevents contamination of the DNA profile, ensuring that only spermatozoal DNA is analyzed.

Inventive Principle:
Principle #2Taking out (Extraction)

2Productivity

If expensive separation technologies are used, then separation efficiency improves, but device complexity and cost increase

Engineering Contradiction:
Improveseparation efficiencyVSAvoidequipment cost
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent replaces complex mechanical separation systems with a magnetic field-based approach. Instead of using expensive flow cytometry, laser dissection, or complex centrifugation systems, the method uses magnetic particles coupled to CD52 markers on spermatozoa that can be separated using simple magnetic fields. This substitution of mechanical systems with magnetic field-based separation significantly reduces equipment cost and complexity while maintaining high separation efficiency.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces magnetic particles as an intermediary between the target cells (spermatozoa) and the separation mechanism. These magnetic particles bind to CD52 markers on spermatozoa and serve as a mediator that enables separation through magnetic fields. This intermediary approach simplifies the separation process compared to direct mechanical or optical methods, reducing both equipment complexity and operational difficulty.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Manufacturing precision

If skilled operators are required for cell separation, then separation precision improves, but ease of operation decreases

Engineering Contradiction:
Improveseparation precisionVSAvoidoperational simplicity
Core Design Contradiction:
Manufacturing precisionVSEase of operation

Solution Approach 1:

The patent applies self-service by designing a system where the magnetic particles automatically bind to CD52 markers on spermatozoa through specific molecular recognition. The separation process becomes self-directed, where the magnetic field naturally attracts and separates magnetized spermatozoa from non-magnetized epithelial cells without requiring skilled manual manipulation. The system performs the separation function autonomously based on the inherent magnetic properties and specific binding, reducing the need for operator expertise.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The patent uses parameter changes by applying a magnetic field as a separable parameter that distinguishes magnetized spermatozoa from non-magnetized cells. By changing the physical state of spermatozoa through magnetic particle coupling, the method creates a clear parameter difference (magnetic susceptibility) that enables simple separation through magnetic field application. This parameter-based approach simplifies operation compared to methods requiring complex manual sorting or skilled interpretation.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method effectively separates spermatozoa from epithelial cells, maintaining DNA integrity and reducing contamination risks, with high recovery rates and compatibility with downstream DNA analysis, using simple and cost-effective protocols.

Implementation Method 1

exposing the plurality of cells to at least one magnetic particle under conditions effective to allow the direct or indirect coupling of the magnetic particle to the specific marker CD52 expressed on the surface of the spermatozoa

Methodology Applied
Scientific EffectMagnetic coupling: Magnetism

Implementation Method 2

contacting said plurality of cells with a serum-free buffer comprising Phosphate buffered saline 1× and about 2-20 mM of EDTA

Methodology Applied
Scientific EffectChelation:

Data Source

PatentUS10060914B2Methods for separating cells
Publication Date: 2018.08.28 CENT HOSPITALIER UNIV VAUDOIS (C H U V)
  • US10060914B2 patent drawing
  • US10060914B2 patent drawing
  • US10060914B2 patent drawing

AI summary

The invention is in the field of analysis of cell populations and cell separation and the compositions obtained thereby. More particularly, the invention concerns a method for separating cells of interest according to a specific marker expressed on their surface.